Task: Answer Verification
Input (English): Question: Is dNA-methylation in C1R a prognostic biomarker for acute myeloid leukemia?
Answer: Analysis of DNAm at C1R provides a simple, robust, and cost-effective biomarker to further complement risk assessment in AML.
Output (English): yes